What is Quest Diagnostics's expected EPS for Q2 2026?

Analysts expect Quest Diagnostics (DGX) to report consensus EPS of approximately $2.82 for Q2 2026. Estimates range from $2.75 to $2.91.

What revenue do analysts expect for Quest Diagnostics in Q2 2026?

The consensus revenue forecast for Quest Diagnostics (DGX) in Q2 2026 is approximately $2.97B. Forecasts range from $2.94B to $3B.

How many analysts cover Quest Diagnostics?

12 analysts contribute to the Quest Diagnostics (DGX) Q2 2026 consensus estimate.

Has Quest Diagnostics beaten earnings estimates recently?

Quest Diagnostics beat analyst EPS estimates in 1 of the last 1 quarter. Quest Diagnostics beat revenue estimates in 1 of 1. In the most recent quarter (Q1 2026), Quest Diagnostics EPS beat by 5.7% and revenue beat by 2.3%.

When does Quest Diagnostics report Q2 2026 earnings?

Quest Diagnostics (DGX) is expected to report Q2 2026 earnings on July 23, 2026 before market open.

DGX Q2 2026 earnings estimate

Consensus EPS · Q2 2026

$2.82

Consensus revenue · Q2 2026

$3B

Analysts

Expected report

Jul 23, 2026

Before open

Predictions locked

Analyst consensus (locked)

Revenue$3B

EPS$2.82

Analyst consensus

Based on estimates from 12 analysts.

Metric	Low	Consensus	High
Revenue	$2.9B	$3B	$3B
EPS	$2.75	$2.82	$2.91
EBITDA	$620.9M	$627.2M	$631.4M
EBIT	$484.8M	$489.8M	$493.1M
Net income	$309.4M	$316.2M	$325.2M

Revenue$3B
EPS$2.82
EBITDA$627.2M
EBIT$489.8M
Net income$316.2M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q1 2026	$2.9B	$2.8B	+2.3%	$2.50	$2.37	+5.7%

Q1 2026+2.3%+5.7%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Quest Diagnostics (DGX) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 1 analyst.

Low: $210.00
Consensus: $223.00
Median: $225.00
High: $236.00
Current: $209.83
Upside: +6.3%

Upside calculated vs most recent trading price of $209.83.

Analyst ratings

Consensus: Hold — based on 34 analyst ratings.

Buy 13Hold 18Sell 3

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 13, 2026	Baird	maintain	Neutral	Neutral
Apr 22, 2026	UBS	maintain	Neutral	Neutral
Apr 22, 2026	Truist Securities	maintain	Hold	Hold
Apr 22, 2026	Barclays	maintain	Overweight	Overweight
Apr 22, 2026	Baird	maintain	Neutral	Neutral
Apr 8, 2026	Evercore ISI Group	maintain	In Line	In Line
Feb 12, 2026	Mizuho	maintain	Outperform	Outperform
Feb 11, 2026	UBS	maintain	Neutral	Neutral
Feb 11, 2026	Truist Securities	maintain	Hold	Hold
Feb 11, 2026	Jefferies	maintain	Buy	Buy

Jul 13, 2026BairdNeutral
Apr 22, 2026UBSNeutral
Apr 22, 2026Truist SecuritiesHold
Apr 22, 2026BarclaysOverweight
Apr 22, 2026BairdNeutral
Apr 8, 2026Evercore ISI GroupIn Line
Feb 12, 2026MizuhoOutperform
Feb 11, 2026UBSNeutral
Feb 11, 2026Truist SecuritiesHold
Feb 11, 2026JefferiesBuy

Frequently asked questions

Quest Diagnostics (DGX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

DGX Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation